FDA unveils a new “green list” import alert aimed at preventing unapproved and potentially unsafe GLP-1 drug ingredients from entering the U.S.
FDA grants CERo Therapeutics fast track status for CER-1236 and its use for treating acute myeloid leukemia.
FDA unveils a new “green list” import alert aimed at preventing unapproved and potentially unsafe GLP-1 drug ingredients from entering the U.S.
FDA grants CERo Therapeutics fast track status for CER-1236 and its use for treating acute myeloid leukemia.
Johns Hopkins’ drug safety expert G. Caleb Alexander says FDA’s recent use of ad hoc expert panels in place of traditional advisory committees risks undermining scientific rigor and public trust.
FDA commissioner Marty Makary says an evaluation of reports contained in the agency’s vaccines adverse event database shows there have been Covid-19 vaccine-related deaths in children and a “proper investigation” is underway.
